Hjem › Fokal segmental glomerulosklerose › Michigan › Ann Arbor
Fokal segmental glomerulosklerose kliniske forsøg i Ann Arbor, MI
6 studier for Fokal segmental glomerulosklerose søger deltagere på steder i og omkring Ann Arbor (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
RekruttererFase 2
- University of Michigan Health System - Ann Arbor- Site Number : 8400010, Ann Arbor
Nephrotic Syndrome Study Network
RekruttererObservationsstudie
- CS Mott Children's Hospital, University of Michigan, Ann Arbor
- University of Michigan Medical Center, Ann Arbor
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
RekruttererFase 2
- C.S. Mott Children's Hospital, Ann Arbor
Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease
RekruttererObservationsstudie
- University of Michigan, Ann Arbor
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
RekruttererFase 3
- University of Michigan, Ann Arbor
Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
RekruttererObservationsstudie
- University of Michigan, Ann Arbor
Fokal segmental glomerulosklerose forsøg i andre byer
- Philadelphia, PA9 studier
- Durham, NC8 studier
- New York City, NY7 studier
- Queens, NY6 studier
- Miami, FL6 studier
- Los Angeles, CA6 studier
- Houston, TX5 studier
- Atlanta, GA5 studier
- Cleveland, OH4 studier
- Chicago, IL4 studier
- Dallas, TX4 studier
- Kansas City, MO4 studier
Andre studier i Ann Arbor
- Prostatakræft27 studier
- Brystkræft26 studier
- Ikke-småcellet lungecancer26 studier
- Kræft (alle typer)25 studier
- Colorektal kræft23 studier
- Lungecancer23 studier
- Hjertesvigt22 studier
- Akut myeloid leukæmi17 studier
- Kardiovaskulær sygdom16 studier
- Bugspytkirtelkræft14 studier
- Melanom12 studier
- Nyrekancer (renocellulært karcinom)12 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.